Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis
High risk of benzo[α]pyrene-induced lung cancer in E160D FEN1 mutant mice
Highlights
► We investigate whether FEN1 mutations cause individuals to be more sensitive to tobacco compounds such as B[α]P. ► We demonstrate that FEN1 is involved in processing of B[α]P lesions and the GEN activity of FEN1 is important for this process. ► Individuals carrying FEN1 mutations that impair its GEN activity will have high risk to develop tobacco-induced cancer.
Introduction
It is generally recognized that tobacco smoke, which contains more than 60 carcinogens, is the major cause of lung cancer [1], [2]. Benzo[α]pyrene (B[α]P), a five-ring polycyclic aromatic hydrocarbon, is a major DNA damaging compound present in tobacco smoke and an environmental pollutant [3]. In the lung, B[α]P interacts with cytochrome p450 enzymes, producing benzo[α]pyrene-trans-7, 8-dihydrodiol-9, 10-epoxide(anti)(+) (BPDE), the metabolite that interacts with DNA to form adducts [4]. Previous studies indicated that B[α]P adducts are mainly repaired via the nucleotide excision repair (NER), which is mediated by Xeroderma Pigmentosum group G (XPG)- and Excision Repair Cross Complementing group 1-Xeroderma Pigmentosum group F (ERCC1-XPF) [5]. Flap endonuclease 1 (FEN1), an XPG homologue [6], possesses flap endonuclease (FEN), exonuclease (EXO), and gap endonuclease (GEN) activities [7], [8], [9]. FEN1 has been suggested to play a critical role in DNA replication, DNA base excision repair (BER), and rescue of stalled replication forks [10], [11]. Decreased FEN1 activity causes abnormal cell proliferation, genomic instability, and tumorigenesis [12]. However, it is unclear whether FEN1 plays a role in repairing B[α]P-induced DNA lesions.
We have recently identified Fen1 mutations and single nucleotide polymorphisms (SNPs) in human cancer patients, particularly human lung cancer patients [13]. Most of these Fen1 mutations displayed deficiency in the EXO and GEN activities [13]. A critical question is whether individuals carrying such mutations or SNPs, which impair FEN1-mediated DNA repair pathways, are more susceptible to the development of tobacco-induced lung cancer. A mouse model carrying the E160D Fen1 mutation (E160D mice) has been generated to mimic these mutations seen in humans. We observed that E160D mice developed lung cancer spontaneously [14]. More recently, we have showed that E160D mice develop early onset of lung cancer after exposure to the base damaging agent methylnitrosourea [15]. It is unclear whether E160D mice are sensitive to tobacco compounds such as B[α]P and develop B[α]P-induced lung cancer. Here, we report that the E160D FEN1 mutation impairs the cleavage of bubble DNA substrates. Consistent with this observation, nuclear extracts (NEs) from E160D mutant cells display defects in repair of B[α]P-induced DNA lesions and accumulate DNA double-stranded breaks and have high frequency of near-tetraploid aneuploidy. Furthermore, E160D mice are susceptible to the development of early onset of B[α]P-induced lung cancer.
Section snippets
Establishment and culturing of MEFs
MEFs were obtained from mice of the 129S1 genetic background. Embryos (E13.5) were isolated and dissected by the treatment with trypsin to produce MEFs. Primary MEFs were cultured at 37 °C with 5% CO2 in Dulbecco's modified Eagle's medium (DMEM; Invitrogen, Grand Island, NY), supplemented with 10% fetal bovine serum (FBS; Invitrogen) and penicillin–streptomycin (Invitrogen) [15].
Cell treatment
B[α]P (50-32-8, Sigma, St. Louis, MO) was dissolved in glyceryl trioctanoate (538-23-8, Sigma). MEFs from the P1
The E160D FEN1 mutation causes defects in the repair of BPDE-induced DNA damage
To assay the efficiency of WT and E160D NEs to repair B[α]P-induced DNA lesions, we prepared damaged DNA substrates by treating plasmid pUC18 DNA with BPDE in vitro. BPDE, the main metabolite of B[α]P, directly attacks DNA, creates DNA adducts predominantly on the N2-positon of guanine, and forms 10S (+)-trans-anti-B[α]P-N2-dG (G*) adducts [18]. To test whether the E160D NEs isolated from the primary MEFs had defects in the repair of B[α]P-induced adducts, we incubated the WT or the E160D NEs
Discussion
Cancer is thought to involve the accumulation of multiple forms of genome instabilities, including DNA mutations and chromosomal aberrations [25]. DNA constantly encounters endogenous and exogenous insults, leading to varying forms of lesions, which, if not properly repaired, may result in genome instabilities and cancer [26], [27]. Epidemiological studies have long suggested that environmental insults, such as B[α]P, and/or genetic variations in DNA repair genes and other related genes are
Conflict of interest statement
No conflicts of interest.
Acknowledgements
We thank the microscopy core facility of City of Hope for technical assistance with immunofluorescence staining and imaging of MEF cells. All protocols involving animal use were approved by the Research Animal Care Committee of City of Hope National Medical Center and Beckman Research Institute in compliance with the Public Health Service Policy on Use of Laboratory Animals. This work was supported by NIH grant R01 CA073764 to B.H.S.
References (38)
- et al.
The critical DNA damage by benzo[α]pyrene in lung tissues of smokers and approaches to preventing its formation
Toxicol. Lett.
(2010) - et al.
Partial functional deficiency of E160D flap endonuclease-1 mutant in vitro and in vivo is due to defective cleavage of DNA substrates
J. Biol. Chem.
(1998) - et al.
Human flap endonuclease structures, DNA double-base flipping, and a unified understanding of the FEN1 superfamily
Cell
(2011) - et al.
Cell cycle-dependent and DNA damage-inducible nuclear localization of FEN-1 nuclease is consistent with its dual functions in DNA replication and repair
J. Biol. Chem.
(2001) - et al.
FEN1 ensures telomere stability by facilitating replication fork re-initiation
J. Biol. Chem.
(2010) - et al.
Distant neighbor base sequence context effects in human nucleotide excision repair of a benzo[α]pyrene-derived DNA lesion
J. Mol. Biol.
(2010) - et al.
Mutational spectra vary with exposure conditions: benzo[α]pyrene in human cells
Mutat. Res.
(1996) - et al.
Chromosomal breakage syndromes and the BRCA1 genome surveillance complex
Trends Mol. Med.
(2001) - et al.
Recognition of RNA polymerase II and transcription bubbles by XPG, CSB, and TFIIH: insights for transcription-coupled repair and Cockayne Syndrome
Mol. Cell
(2005) - et al.
Ordered conformational changes in damaged DNA induced by nucleotide excision repair factors
J. Biol. Chem.
(2004)
Repair of oxidized bases in DNA bubble structures by human DNA glycosylases NEIL1 and NEIL2
J. Biol. Chem.
Role of non-homologous end joining (NHEJ) in maintaining genomic integrity
DNA Repair (Amst.)
DNA double-strand break repair: from mechanistic understanding to cancer treatment
DNA Repair (Amst.)
Tobacco use, cancer causation and public health impact
J. Intern. Med.
Genetic susceptibility to tobacco-related cancer
Oncogene
Repair of DNA lesions induced by polycyclic aromatic hydrocarbons in human cell-free extracts: involvement of two excision repair mechanisms in vitro
Carcinogenesis
DNA damage and repair: from molecular mechanisms to health implications
Antioxid. Redox Signal.
Functional analysis of point mutations in human flap endonuclease-1 active site
Nucl. Acids Res.
Multiple but dissectible functions of FEN-1 nucleases in nucleic acid processing, genome stability and diseases
Bioessays
Cited by (17)
Lighting-up aptamer transcriptional amplification for highly sensitive and label-free FEN1 detection
2023, Spectrochimica Acta - Part A: Molecular and Biomolecular SpectroscopyCitation Excerpt :The under-expression of FEN1 can inhibit DNA replication and repair, which may lead to many diseases [10]. Previous studies have shown that FEN1 is over-expressed in several cancers, including liver cancer, epithelial ovarian cancer, lung cancer, aggressive breast cancer, testicular cancer, prostate cancer and gastric cancer [11–15]. Therefore, FEN1 has been considered as a typical biomarker for the diagnosis of various cancers [16,17].
Flap endonuclease 1 (FEN1) as a novel diagnostic and prognostic biomarker for gastric cancer
2021, Clinics and Research in Hepatology and GastroenterologyCitation Excerpt :However, the role of FEN1 in multiple pathways is somewhat contradictory. A tumour suppressor function of FEN1 was shown in preclinical models [17–20]. In a mouse model, haploinsufficiency of FEN1 resulted in enhanced tumour progression with increased adenocarcinoma and poor survival [18].
DNA repair as an emerging target for COPD-lung cancer overlap
2019, Respiratory InvestigationCitation Excerpt :Combined deficiencies of Ogg1 and Mth1, which is involved in MMR, results in decreased lung tumor development, possibly from exhaustion of the dNTP pool, suggesting the likely importance and complex interplay of multiple DNA repair pathways in lung cancer development [71,72]. A specific E160D mutation in FEN1, which is involved in BER, has also been shown to increase lung cancer development with age and carcinogen exposure in mice [73]. Deficiency in the MMR protein, MGMT, leads to lung tumor development in mice treated with the alkylating carcinogens, N-nitroso-N-methylurea (NMU) and dimethylnitrosamine (DMN).
Overexpression of Flap Endonuclease 1 Correlates with Enhanced Proliferation and Poor Prognosis of Non–Small-Cell Lung Cancer
2018, American Journal of PathologyGenomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer
2014, Molecular OncologyCitation Excerpt :FEN1 may have a role in carcinogenesis. A tumour suppressor function for FEN1 has been shown in preclinical models (Henneke et al., 2003a, 2003b; Kucherlapati et al., 2007; Kucherlapati et al., 2002; Wu et al., 2012; Xu et al., 2011). Whereas, FEN1 homologous knock out in mice is embryonically lethal FEN1 heterozygous mice are viable (Larsen et al., 2003).
- 1
These authors contributed to the work equally and would like to be recognized as co-first authors.